Schedule 13G ownership disclosure

CAMP4 Therapeutics Corp.

Common Stock, par value $0.0001 per share · CUSIP: 13463J101

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • HarbourVest Partners L.P.

    Shares: 1,271,948 · Class: 6.3%

  • HarbourVest Partners, LLC

    Shares: 1,271,948 · Class: 6.3%

  • SMRS-TOPE LLC

    Shares: 1,271,948 · Class: 6.3%

  • HVST-TOPE LLC

    Shares: 1,271,948 · Class: 6.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-071166
Form type
SCHEDULE 13G
Filer
Camp4 Therapeutics Corp
CIK
CIK 1736730
Filed
May 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub